OXY Stock Analysis: Occidental Petroleum | NYSE
Oil & Gas E&P | NYSE, USA | Market Cap: 56.360m USD | 12M Return: 36.1% | US6745991058 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 547M
EPS Trend: -49.0%
Qual. Beats: 4
Rev. Trend: -81.1%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Occidental Petroleum Corporation (NYSE: OXY) is a Houston, Texas-based integrated oil and gas company founded in 1920 that operates in two main segments: Oil and Gas (upstream exploration and production of oil/condensate, natural gas liquids, and natural gas in the U.S. and internationally) and Midstream and Marketing (gathering, processing, transporting, storing, and marketing hydrocarbons, along with carbon dioxide and power). The company is classified within the GICS Integrated Oil & Gas sub-industry, meaning it participates across multiple stages of the energy value chain rather than focusing solely on production.
A notable feature of Occidentals midstream operations is its involvement with carbon dioxide, which is commonly used in enhanced oil recovery (EOR) and is increasingly relevant to carbon capture, utilization, and storage (CCUS) efforts within the broader energy sector. As a large-cap energy issuer, OXYs performance is typically tied to global crude oil prices, production volumes, and capital expenditure cycles that characterize the upstream industry.
- Permian Basin oil production growth boosts Oil and Gas segment revenue
- Berkshire Hathaway increases stake in Occidental signaling capital allocation confidence
- Carbon capture and Direct Air Capture projects drive low-carbon regulatory compliance revenue
- Midstream and Marketing margins expand on NGL and natural gas processing demand
- Debt reduction from Anadarko acquisition proceeds improves balance sheet leverage ratio
| Net Income: 8.06b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.58 > 1.0 |
| NWC/Revenue: 6.27% < 20% (prev -2.30%; Δ 8.57% < -1%) |
| CFO/TA 0.15 > 3% & CFO 11.9b > Net Income 8.06b |
| Net Debt (21.9b) to EBITDA (13.4b): 1.63 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (1.00b) vs prev 3.41% < -2% |
| Gross Margin: 43.12% > 18% (prev 33.10%; Δ 10.02% > 0.5%) |
| Asset Turnover: 30.79% > 50% (prev 31.75%; Δ -0.96% > 0%) |
| Interest Coverage Ratio: 9.24 > 6 (EBIT TTM 6.05b / Interest Expense TTM 654.0m) |
| A: 0.02 (Total Current Assets 11.0b - Total Current Liabilities 9.43b) / Total Assets 79.8b |
| B: 0.27 (Retained Earnings 21.9b / Total Assets 79.8b) |
| C: 0.07 (EBIT TTM 6.05b / Avg Total Assets 81.6b) |
| D: 0.72 (Book Value of Equity 36.0b / Total Liabilities 50.2b) |
| Altman-Z'' = 2.28 = BBB |
| DSRI: 1.21 (Receivables 4.41b/3.84b, Revenue 25.1b/26.5b) |
| GMI: 0.77 (GM 33.10% / 43.12%) |
| AQI: -11.67 (AQ_t -0.85 / AQ_t-1 0.07) |
| SGI: 0.95 (Revenue 25.1b / 26.5b) |
| TATA: -0.05 (NI 8.06b - CFO 11.9b) / TA 79.8b) |
| Beneish M = -10.62 (Cap -4..+1) = AAA |
As of November 11, 2026, the stock is trading at USD 55.76 with a total of 11,164,066 shares traded. Over the past week, the price has changed by -8.17%, over one month by -7.24%, over three months by -4.49% and over the past year by +36.05%.
Current recommended Stop Loss: 51.20 (which is 8.2% or 2.5 ATR below the current price).
Occidental Petroleum has received a consensus analysts rating of 3.79. Therefore, it is recommended to hold OXY.
- StrongBuy: 10
- Buy: 2
- Hold: 16
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 70.7 | 26.9% |
P/E Trailing = 16.017
P/E Forward = 10.929
P/S = 2.3556
P/B = 1.6844
P/EG = 0.8457
Revenue TTM = 25.1b USD
EBIT TTM = 6.05b USD
EBITDA TTM = 13.4b USD
Long Term Debt = 19.8b USD (from longTermDebt, last fiscal year)
Short Term Debt = 2.12b USD (from shortTermDebt, last fiscal year)
Debt = 25.8b USD (from shortLongTermDebtTotal, last fiscal year) + Leases 1.83b
Net Debt = 21.9b USD (calculated: Debt 25.8b - CCE 3.88b)
Enterprise Value = 78.3b USD (56.4b + Debt 25.8b - CCE 3.88b)
Interest Coverage Ratio = 9.24 (Ebit TTM 6.05b / Interest Expense TTM 654.0m)
EV/FCF = 11.67x (Enterprise Value 78.3b / FCF TTM 6.71b)
FCF Yield = 8.57% (FCF TTM 6.71b / Enterprise Value 78.3b)
FCF Margin = 26.67% (FCF TTM 6.71b / Revenue TTM 25.1b)
Net Margin = 32.07% (Net Income TTM 8.06b / Revenue TTM 25.1b)
Gross Margin = 43.12% ((Revenue TTM 25.1b - Cost of Revenue TTM 14.3b) / Revenue TTM)
Gross Margin QoQ = none% (prev 81.03%)
Tobins Q-Ratio = 0.98 (Enterprise Value 78.3b / Total Assets 79.8b)
Interest Expense / Debt = 2.54% (Interest Expense 654.0m / Debt 25.8b)
Taxrate = 9.87% (688.0m / 6.97b)
NOPAT = 5.45b (EBIT 6.05b * (1 - 9.87%))
Current Ratio = 1.17 (Total Current Assets 11.0b / Total Current Liabilities 9.43b)
Debt / Equity = 0.72 (Debt 25.8b / totalStockholderEquity, last fiscal year 36.0b)
Debt / EBITDA = 1.63 (Net Debt 21.9b / EBITDA 13.4b)
Debt / FCF = 3.27 (Net Debt 21.9b / FCF TTM 6.71b)
Total Stockholder Equity = 38.2b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.87% (Net Income 8.06b / Total Assets 79.8b)
RoE = 21.08% (Net Income TTM 8.06b / Total Stockholder Equity 38.2b)
RoCE = 10.41% (EBIT 6.05b / Capital Employed (Equity 38.2b + L.T.Debt 19.8b))
RoIC = 7.65% (NOPAT 5.45b / Invested Capital 71.2b)
WACC = 5.50% (E(56.4b)/V(82.1b) * Re(6.97%) + D(25.8b)/V(82.1b) * Rd(2.54%) * (1-Tc(0.10)))
Discount Rate = 6.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 84.06 | Cagr: 2.93%
[DCF] Terminal Value 77.97% ; FCFF base≈5.63b ; Y1≈6.46b ; Y5≈9.50b
[DCF] Fair Price = 121.2 (EV 143b - Net Debt 21.9b = Equity 121b / Shares 999.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -49.02 | EPS CAGR: -11.28% | SUE: 3.69 | # QB: 4
Revenue Correlation: -81.13 | Revenue CAGR: -5.05% | SUE: -0.14 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.47 | Chg30d=+16.37% | Revisions=+76% | Analysts=23
EPS current Year (2026-12-31): EPS=6.87 | Chg30d=+11.94% | Revisions=+86% | GrowthEPS=+210.9% | GrowthRev=+26.0%
EPS next Year (2027-12-31): EPS=5.02 | Chg30d=+24.80% | Revisions=+59% | GrowthEPS=-27.0% | GrowthRev=-5.9%
[Analyst] Revisions Ratio: +81% (up=52, down=4)